Skip to main content
HNCIG consensus on endpoint definitions in recurrent and metastatic HNSCC trials
  1. Home
  2. Resources
  3. HNCIG consensus on endpoint definitions in recurrent and metastatic HNSCC trials

HNCIG assessed endpoint definitions from phase 3 trials or trials considered practice-changing for patients with recurrent or metastatic mucosal head and neck squamous cell carcinoma, published between 2008 and 2021.

Published in The Lancet.


View Resource
Back to Resources